Seven Bridge Financial Group, LLC Abbott Laboratories Transaction History

Seven Bridge Financial Group, LLC

$478 Million
Q1 2025

A detailed history of Seven Bridge Financial Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Seven Bridge Financial Group, LLC holds 27,434 shares of ABT stock, worth $3.66 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares

27,434

Previous 34,453 20.37%

Holding current value

$3.66 Million

Previous $3.9 Million 6.6%

% of portfolio

0.76%

Previous 0.79%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$111.1 - $140.22 $779,810 - $984,204	-7,019 Reduced 20.37%	27,434 $3.64 Million
Q4 2024 Feb 12, 2025	BUY	$111.93 - $119.39 $49,137 - $52,412	439 Added 1.29%	34,453 $3.9 Million
Q3 2024 Nov 12, 2024	BUY	$100.07 - $118.13 $115,280 - $136,085	1,152 Added 3.51%	34,014 $3.88 Million
Q2 2024 Aug 09, 2024	BUY	$100.73 - $112.44 $43,716 - $48,798	434 Added 1.34%	32,862 $3.41 Million
Q1 2024 May 10, 2024	SELL	$109.52 - $120.96 $233,606 - $258,007	-2,133 Reduced 6.17%	32,428 $3.69 Million
Q4 2023 Jan 22, 2024	SELL	$90.19 - $110.4 $8,117 - $9,936	-90 Reduced 0.26%	34,561 $3.8 Million
Q3 2023 Oct 25, 2023	SELL	$95.53 - $114.62 $11,177 - $13,410	-117 Reduced 0.34%	34,651 $3.36 Million
Q2 2023 Jul 26, 2023	SELL	$100.78 - $112.29 $9,775 - $10,892	-97 Reduced 0.28%	34,768 $3.79 Million
Q1 2023 Apr 20, 2023	BUY	$96.86 - $114.01 $1,549 - $1,824	16 Added 0.05%	34,865 $3.53 Million
Q4 2022 Jan 26, 2023	BUY	$95.06 - $111.52 $4,087 - $4,795	43 Added 0.12%	34,849 $0
Q3 2022 Oct 17, 2022	BUY	$96.76 - $112.03 $54,379 - $62,960	562 Added 1.64%	34,806 $3.37 Million
Q2 2022 Jul 12, 2022	BUY	$102.07 - $123.37 $51,443 - $62,178	504 Added 1.49%	34,244 $3.72 Million
Q1 2022 Apr 15, 2022	SELL	$114.02 - $139.04 $232,030 - $282,946	-2,035 Reduced 5.69%	33,740 $3.99 Million
Q4 2021 Jan 20, 2022	BUY	$115.53 - $141.46 $4.13 Million - $5.06 Million	35,775 New	35,775 $5.04 Million
Q4 2021 Jan 20, 2022	SELL	$115.53 - $141.46 $3.92 Million - $4.8 Million	-33,908 Closed	0 $0
Q3 2021 Oct 14, 2021	SELL	$116.66 - $129.06 $122,609 - $135,642	-1,051 Reduced 3.01%	33,908 $4.01 Million
Q2 2021 Jul 26, 2021	BUY	$105.79 - $124.53 $118,273 - $139,224	1,118 Added 3.3%	34,959 $4.05 Million
Q1 2021 Apr 20, 2021	BUY	$108.84 - $128.23 $4,135 - $4,872	38 Added 0.11%	33,841 $4.06 Million
Q4 2020 Jan 19, 2021	BUY	$105.0 - $114.42 $99,225 - $108,126	945 Added 2.88%	33,803 $3.7 Million
Q3 2020 Oct 22, 2020	SELL	$91.64 - $111.29 $162,386 - $197,205	-1,772 Reduced 5.12%	32,858 $3.58 Million
Q2 2020 Jul 24, 2020	SELL	$76.57 - $98.0 $134,456 - $172,088	-1,756 Reduced 4.83%	34,630 $3.17 Million
Q1 2020 Apr 16, 2020	BUY	$62.82 - $91.86 $262,524 - $383,882	4,179 Added 12.98%	36,386 $2.87 Million
Q4 2019 Jan 17, 2020	SELL	$78.51 - $87.4 $61,316 - $68,259	-781 Reduced 2.37%	32,207 $2.8 Million
Q3 2019 Oct 09, 2019	SELL	$81.84 - $88.74 $22,587 - $24,492	-276 Reduced 0.83%	32,988 $2.76 Million
Q2 2019 Jul 15, 2019	SELL	$72.88 - $85.0 $69,819 - $81,430	-958 Reduced 2.8%	33,264 $2.8 Million
Q1 2019 May 14, 2019	SELL	$66.22 - $80.06 $15,826 - $19,134	-239 Reduced 0.69%	34,222 $2.74 Million
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $1.2 Million - $1.35 Million	18,241 Added 112.46%	34,461 $2.49 Million
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $10,033 - $12,104	-165 Reduced 1.01%	16,220 $1.19 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $2,648 - $2,922	-46 Reduced 0.28%	16,385 $999,000
Q1 2018 May 11, 2018	SELL	$56.27 - $63.62 $24,983 - $28,247	-444 Reduced 2.63%	16,431 $985,000
Q4 2017 Feb 20, 2018	SELL	$53.68 - $57.47 $56,041 - $59,998	-1,044 Reduced 5.83%	16,875 $963,000
Q3 2017 Nov 13, 2017	SELL	$48.06 - $53.64 $7,497 - $8,367	-156 Reduced 0.86%	17,919 $956,000
Q2 2017 Aug 14, 2017	BUY	N/A	18,075	18,075 $879,000

Others Institutions Holding ABT

# of Institutions

3,545

Shares Held

1.38B

Call Options Held

9.75M

Put Options Held

8.87M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $233B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Bridge Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Seven Bridge Financial Group, LLC with notifications on news.

Account

Seven Bridge Financial Group, LLC Abbott Laboratories Transaction History